Jones Day continues to handle high-stakes merger clearances for its domestic and international client base, as well as representing in DOJ and FTC investigations arising from proposed mergers and high-stakes litigation. The practice is steered by Craig Waldman, a former attorney in the FTC’s Mergers I division, who has specific expertise in the tech, life sciences and finance sectors. In a key demonstration of the firm’s international expertise, Michael Knight represented Evoqua Water Technologies Corp. in its $7.5bn stock-for-stock merger with Xylem Inc, a deal requiring approvals in multiple jurisdictions. Ryan Thomas is noted for his cross-border expertise, and is particularly active in the life sciences, AI and consumer goods sectors, while Aimee DeFilippo regularly represents clients before the DOJ Antitrust Division, FTC, and international antitrust enforcement authorities. The team has been bolstered by several hires in 2023, including Koren Wong-Ervin from Axinn Veltrop & Harkrider, Peter Schwingler from Stinson LLP, and Kevin Hart from the DOJ. Attorneys are based in Washington DC.

Legal 500 Editorial commentary

Key clients

ABS Group
Astellas Pharma Inc.
Axon Enterprise, Inc.
Eastman Chemical Company
Evoqua Water Technologies Corp.
Riverside Company
Sega Sammy Holdings
TopBuild Corporation
Ubisoft

Work highlights

Served as antitrust counsel to Evoqua Water Technologies Corp. in its USD 7.5 billion stock-for-stock merger with Xylem Inc.
Provided antitrust counsel to Astellas Pharma Inc. in its USD 5.9 billion acquisition of Iveric bio, Inc.
Successfully defended Axon in the FTC’s administrative litigation challenging the company’s 2018 acquisition of VieVu.